MCID: PLC007
MIFTS: 47

Placental Abruption malady

Category: Fetal diseases

Aliases & Classifications for Placental Abruption

About this section

Aliases & Descriptions for Placental Abruption:

Name: Placental Abruption 11 13
Abruptio Placentae 11 49 67
 
Abortion, Threatened 38
Abruptio Placenta 11

Classifications:



External Ids:

Disease Ontology11 DOID:9667
ICD1029 O20.0
ICD9CM31 640.0, 640.03
MeSH38 D000033
NCIt44 C112857

Summaries for Placental Abruption

About this section
Disease Ontology:11 A placenta disease that is characterized by separation of the placental lining from the uterus of the mother.

MalaCards based summary: Placental Abruption, also known as abruptio placentae, is related to thrombophilia and kidney cortex necrosis, and has symptoms including false labor An important gene associated with Placental Abruption is MTHFR (Methylenetetrahydrofolate Reductase), and among its related pathways are Glypican 1 network and VEGF binds to VEGFR leading to receptor dimerization. Affiliated tissues include placenta, uterus and testes, and related mouse phenotypes are integument and immune system.

Wikipedia:70 Placental abruption (also known as abruptio placentae) is a complication of pregnancy, wherein the... more...

Related Diseases for Placental Abruption

About this section

Diseases related to Placental Abruption via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 162)
idRelated DiseaseScoreTop Affiliating Genes
1thrombophilia29.4APOH, F2, F5, MTHFR, SERPINC1
2kidney cortex necrosis11.1
3michels caskey syndrome10.6F5, MTHFR
4congenital stenosis of the inferior vena cava10.6F5, MTHFR
5ameloblastic carcinoma10.6F5, MTHFR
6coenzyme q cytochrome c reductase deficiency of10.6APOH, F5
7rasa1-related disorders10.6F2, MTHFR
8typhoid fever10.5F2, MTHFR
9bartholin's gland adenoma10.5F2, F5
10onychocytic matricoma10.5APOH, F5
11tympanosclerosis10.5F2, F5
12facioscapulohumeral muscular dystrophy 110.5F2, F5
13west nile fever10.5F2, F5
14cholesterol embolism10.5APOH, F2
15idiopathic central precocious puberty10.4F2, F5
16infantile-onset ascending hereditary spastic paralysis10.4F2, F5
17irak4 deficiency10.4F2, F5
18complex regional pain syndrome10.4APOH, MTHFR
19hepatic fibrosis renal cysts mental retardation10.4F5, SERPINC1
20acute zonal occult outer retinopathy10.4F2, F5, MTHFR
21homocystinuria due to defect in methylation cbl g10.4F2, F5, MTHFR
22primary pigmented nodular adrenocortical disease10.4F2, F5, MTHFR
23hepatocellular adenoma10.4F2, F5, MTHFR
24ariboflavinosis10.4F2, SERPINC1
25thrombocytopenia with elevated serum iga and renal disease10.4F2, F5, MTHFR
26myiasis10.4F2, SERPINC1
27psychosexual disorder10.3F2, MTHFR
28cavernous hemangioma of face10.3F2, SERPINC1
29marek disease10.3F2, SERPINC1
30ovarian gonadoblastoma10.3F2, SERPINC1
31milk allergy10.3F2, SERPINC1
32pregnancy loss, recurrent 110.3APOH, F5, MTHFR
33spleen cancer10.3F2, SERPINC1
34cervical spina bifida cystica10.3MTHFD1, MTHFR
35catatrichy10.3APOH, F5, MTHFR
36thoracolumbosacral spina bifida cystica10.3MTHFD1, MTHFR
37total spina bifida cystica10.3MTHFD1, MTHFR
38upper thoracic spina bifida aperta10.3MTHFD1, MTHFR
39psychologic dyspareunia10.3F2, THBD
40occipital encephalocele10.3MTHFD1, MTHFR
41cranial meningocele10.3MTHFD1, MTHFR
42charcot-marie-tooth disease10.3F2, F5, MTHFR
43dmd-related dilated cardiomyopathy10.3F2, SERPINC1
44myelocystocele10.3MTHFD1, MTHFR
45cervicothoracic spina bifida aperta10.3MTHFD1, MTHFR
46classic congenital lipoid adrenal hyperplasia due to star deficency10.3APOH, F2, F5
47open iniencephaly10.3MTHFD1, MTHFR
48schizencephaly10.3F5, MTHFR
49lateral cystocele10.3F2, SERPINC1
50closed iniencephaly10.3MTHFD1, MTHFR

Graphical network of the top 20 diseases related to Placental Abruption:



Diseases related to placental abruption

Symptoms for Placental Abruption

About this section

UMLS symptoms related to Placental Abruption:


false labor

Drugs & Therapeutics for Placental Abruption

About this section

Drugs for Placental Abruption (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 121)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MethyldopaapprovedPhase 414555-30-638853
Synonyms:
(-)-3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Alanine Sesqui-Hydrate
(-)-a-methyldopa
(-)-alpha-methyldopa
(-)-methyldopa
(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid
(S)-(-)-a-methyldopa
(S)-(-)-alpha-Methyldopa
(S)-(-)-alpha-methyldopa
133161-54-3
1339-75-9
2-Methyl-3-(3,4-dihydroxyphenyl)alanine
3,4-Dihydroxy-2-methylphenylalanine (ACD/Name 4.0)
3-(3,4-DIHYDROXYPHENYL)-2-METHYL-L-ALANINE
3-Hydroxy-.alpha.-methyl-L-tyrosine
3-Hydroxy-alpha-methyl-L-tyrosine
4290-08-8
555-30-6
779-08-8
AC-11671
AC1L20K1
AC1Q29EL
AC1Q29EM
AMD
Aldoclor-150
Aldoclor-250
Aldomet
Aldomet (TN)
Aldometil
Aldomin
Aldoril 15
Aldoril 25
Aldoril D30
Aldoril D50
Aldoril, Dopamet, Dopegyt, Methyldopa
Alpha medopa
Alphamethyldopa
Anhydrous methyldopa
Apo Methyldopa Tab 125mg
Apo Methyldopa Tab 250mg
Apo Methyldopa Tab 500mg
Apo-Methyldopa
Apo-methyldopa
BIDD:GT0620
BPBio1_000365
BSPBio_000331
BSPBio_002021
Bayer 1440 L
Baypresol
Becanta
C07194
CCRIS 4671
CHEBI:61058
CHEMBL459
CID38853
D08205
DB00968
DivK1c_000142
Dopamet
Dopamethyperpax
Dopatec
Dopegit
Dopegyt
Dopergit
EINECS 209-089-2
EU-0100853
Grospisk
HMS1569A13
HMS1920N09
HMS2090B11
HMS2091F04
HMS500H04
HSDB 218
Hyperpax
Hypolag
IDI1_000142
KBio1_000142
KBio2_001417
KBio2_003985
KBio2_006553
KBio3_001521
KBioGR_000547
KBioSS_001417
L(-)-a-Methylalanine
L(-)-alpha-Methylalanine
L(-)-beta-(3,4-Dihydroxyphenyl)-alpha-methylalanine
L-(-)-3-(3,4-Dihydroxyphenyl)-2-methyl-Alanine
L-(-)-3-(3,4-Dihydroxyphenyl)-2-methylalanine
L-(-)-a-Methyl-a-methyl-Aldomin
L-(-)-alpha-Methyl-alpha-methyl-Aldomin
L-(-)-alpha-Methyl-beta-(3,4-dihydroxyphenyl)alanine
L-(a-MD)
L-(alpha-Md)
L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid
L-Methyl Dopa
L-Methyl dopa
 
L-Methyldopa
L-a-Methyl-(3, 4-dihydroxyphenyl)alanine
L-a-Methyldopa
L-alpha-Methyl DOPA
L-alpha-Methyl-(3, 4-dihydroxyphenyl)alanine
L-alpha-Methyl-3,4-dihydroxyphenylalanine
L-alpha-Methyldopa
LS-216
LT00847269
Lopac0_000853
METHYL DOPA (SEE ALSO METHYL DOPA SESQUIHYDRATE)
MK 351
MK-351
MLS000028644
Medomet
Medopa
Medopal
Medopren
Methoplain
Methyl dopa
Methyl-L-dopa
Methyldopa
Methyldopa (INN)
Methyldopa (L,-)
Methyldopa (anhydrous)
Methyldopa 125 Tab 125mg
Methyldopa 250 Tab
Methyldopa 500 Tab 500mg
Methyldopa anhydrous
Methyldopate
Methyldopate HCL
Methyldopum
Methyldopum [INN-Latin]
Metildopa
Metildopa [INN-Spanish]
Mk. b51
MolPort-001-792-485
NCGC00024667-01
NCGC00024667-02
NCGC00024667-03
NCGC00024667-05
NCGC00024667-06
NCGC00024667-08
NCI-C55721
NINDS_000142
NSC 169916
NSC169916
Novo-Medopa Tab 125mg
Novo-Medopa Tab 250mg
Novo-Medopa Tab 500mg
Novomedopa
Nr.C 2294
Nu-Medopa
Nu-Medopa Tab 125mg
Nu-Medopa Tab 250mg
Nu-Medopa Tab 500mg
Nu-medopa
Presinol
Presolisin
Prestwick0_000326
Prestwick1_000326
Prestwick2_000326
Prestwick3_000326
Prestwick_732
S1642_Selleck
SMR000059170
SPBio_001056
SPBio_002252
SPECTRUM1500403
Sedometil
Sembrina
Spectrum2_001068
Spectrum3_000501
Spectrum4_000054
Spectrum5_001295
Spectrum_000937
Tocris-0584
UNII-56LH93261Y
a-Methyl dopa
a-Methyl-L-3,4-dihydroxyphenylalanine
a-Methyl-L-dopa
a-Methyldopa (van)
alpha Medopa
alpha-Methyl dopa
alpha-Methyl-L-3,4-dihydroxyphenylalanine
alpha-Methyl-L-dopa
alpha-Methyl-beta-(3,4-dihydroxyphenyl)-L-alanine
alpha-Methyldihydroxyphenylalanine
alpha-Methyldopa
alpha-Methyldopa (VAN)
alpha-Methyldopa (van)
alpha-methyl-L-dopa
l-3-(3,4-Dihydroxyphenyl)-2-methylalanine
l-alpha-Methyldopa
levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine
α-Methyl dopa
α-methyl-L-dopa
2
Progesteroneapproved, vet_approvedPhase 4, Phase 353757-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
3
Magnesium Sulfateapproved, vet_approvedPhase 4, Phase 31687487-88-924083
Synonyms:
(C10-C16) Alkylalcohol sulfuric acid, magnesium salt
00627_FLUKA
10028-26-9
10034-99-8 (heptahydrate)
13143_RIEDEL
13143_SIAL
139939-75-6
18939-43-0
203726_ALDRICH
208094_SIAL
34276_FLUKA
34276_RIEDEL
38146_FLUKA
38146_RIEDEL
63126_FLUKA
63136_FLUKA
63136_SIAL
63139_FLUKA
63139_SIAL
68081-97-0
7487-88-9
AC1L2N76
AC1LAX36
AC1Q1U66
AI3-02029
Bitter salt
C10-C16 Alkyl alcohol sulfuric acid magnesium salt
CCRIS 8411
CHEBI:32599
CID24083
CPD0-2390
Caswell No. 534
D008278
DB00653
EINECS 231-298-2
EINECS 233-073-4
EINECS 242-691-3
EINECS 268-365-0
EPA Pesticide Chemical Code 050503
Epsom salt
HSDB 664
Hair salt
Heptahydrate Magnesium Sulfate
Kieserite [as monohydrate]
LS-88605
M2643_SIGMA
M3409_SIGMA
 
M7506_SIAL
M8150_SIGMA
MAGNESIUM SULFATE
Magnesium Sulfate In Plastic Container
Magnesium Sulfate, Heptahydrate
Magnesium Sulphate Hydrate
Magnesium bisulfate
Magnesium hydrogensulphate
Magnesium sulfate
Magnesium sulfate (1:1)
Magnesium sulfate anhydrous
Magnesium sulfate dried
Magnesium sulfate heptahydrate
Magnesium sulfate hexahydrate
Magnesium sulfate in dextrose 5% in plastic container
Magnesium sulfate solution
Magnesium sulphate
Magnesium sulphate anhydrous
Magnesium sulphate dried
Magnesium sulphate heptahydrate
Magnesium(II) sulfate
Magnesium(ii) sulfate
Magnesiumsulfat
MgSO4
MolPort-003-925-000
NSC 146179
OT-S
OT-S (drying agent)
SDA 15-062-07
Sal Angalis
Sal De sedlitz
Sal amarum
Sal anglicum
Sal catharticum
Sal seidlitense
Salts of england
Sel d'angleterre
Sulfate, Magnesium
Sulfuric acid magnesium salt
Sulfuric acid magnesium salt (1:1)
Sulfuric acid magnesium salt (VAN)
Sulfuric acid, C10-16 alkyl ester, magnesium salt
Sulfuric acid, magnesium salt
Sulfuric acid, magnesium salt (1:1)
Sulfuric acid, mono-C10-16-alkyl esters, magnesium salts
Tomix OT
UNII-DE08037SAB
UNII-ML30MJ2U7I
magnesium(2+) ion sulfate
4
Oxytocinapproved, vet_approvedPhase 4, Phase 3, Phase 140850-56-6439302, 53477758
Synonyms:
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
(Arg8)-Vasopressin
(Arg8)-Vasotocin
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
50-56-6
AC1L9735
Argipressin
Argpressin Acetate
BCBcMAP01_000094
Biotinyl-(Arg8)-Vasopressin
C00746
CHEBI:492195
CHEBI:7872
CHEMBL395429
CID439302
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
D00089
Disulfide bridge Cys1-Cys6
Gly-Leu-Pro-c
HS-2021
 
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
MolPort-003-938-941
NCGC00167132-01
O3251_SIGMA
O4375_SIGMA
OXT
OXYTOCIN
Ocytocin
Oxitocina
Oxytocic hormone
Oxytocin (JP15/USP/INN)
Oxytocin (TN)
Oxytocin 10 Usp Units In Dextrose 5%
Oxytocin 20 Usp Units In Dextrose 5%
Oxytocin 5 Usp Units In Dextrose 5%
Oxytocin Acetate
Oxytocin injection
Oxytocine
Oxytocinum
Pitocin
Pitocin (TN)
Syntocinon
Syntocinon (TN)
TI-001
alpha-Hypophamine
nchembio.184-comp2
5
LumefantrineapprovedPhase 414582186-77-46437380
Synonyms:
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol
(±)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol
120583-69-9
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl]ethanol
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
2-Dibutylamino-1-[2,7-dichloro-9-(4-chloro-benzylidene)-9H-fluoren-4-yl]-ethanol
2-Dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol
82186-77-4
AC-4542
AC1O5NKD
Benflumetol
Bio-0132
C30H32Cl3NO
 
CHEBI:156095
CHEMBL38827
CID6437380
Coartem
D03821
DB06708
HSDB 7210
I14-7746
LS-177674
Lumefantrine
Lumefantrine (INN)
Lumefantrine [INN:BAN]
MolPort-006-394-826
NCGC00167490-01
UNII-F38R0JR742
dl-Benflumelol
6
SulfadoxineapprovedPhase 41282447-57-617134
Synonyms:
2447-57-6
4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide
4-Sulfanilamido-5,6-dimethoxypyrimidine
4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide
4-amino-N-[5,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide
46810_RIEDEL
5-25-13-00306 (Beilstein Handbook Reference)
6-(4-Aminobenzenesulfonamido)-4,5-dimethoxypyrimidine
AB00514044
AC-11921
AC1L29DT
AC1Q46GG
Ambap2447-57-6
BPBio1_001286
BRD-K55250441-001-03-1
BRN 0625453
BSPBio_001168
C07630
CAS-2447-57-6
CHEBI:9329
CHEMBL1539
CID17134
D00580
DB01299
EINECS 219-504-9
Fanasil
Fanzil
HMS1571K10
HMS2090P07
HMS2094C19
I09-0529
LS-31247
MLS002154150
MolPort-003-850-341
N'-(5,6-Dimethoxy-4-pyrimidyl)sulfanilamide
N(sup 1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
 
N1-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
NCGC00016612-01
NCGC00016612-02
Orthosulfin
Prestwick0_001094
Prestwick1_001094
Prestwick2_001094
Prestwick3_001094
Ro 4-4393
Ro-4-4393
S2511_Selleck
S7821_SIGMA
SMR000857259
SPBio_003054
SULFADOXINE
Sanasil: Sulfadoxine: Sulformetoxin
Solfadossina
Solfadossina [DCIT]
Sulfadoxin
Sulfadoxina
Sulfadoxina [INN-Spanish]
Sulfadoxine
Sulfadoxine (JAN/USP/INN)
Sulfadoxine [USAN:INN:BAN:JAN]
Sulfadoxinum
Sulfadoxinum [INN-Latin]
Sulformethoxine
Sulformetoxine
Sulforthomidine
Sulphadoxine
Sulphormethoxine
Sulphormetoxin
Sulphorthodimethoxine
UNII-88463U4SM5
WR 4073
WR 4873
ZINC00002094
7
Clindamycinapproved, vet_approvedPhase 416818323-44-929029
Synonyms:
13441-63-9
16669-21-9
18323-44-9
21462-39-5 (mono-hydrochloride)
24620-78-8
24696-19-3
58207-19-5
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-Chloro-7-deoxylincomycin
7-Chlorolincomycin
7-Deoxy-7(S)-chlorolincomycin
AC1L1EGQ
AC1L1GLA
AC1L9JV8
AC1MHD7N
AC1MHE1M
AC1MHUOE
AC1MHX4G
AC1NWAKO
AC1O7ENS
AC1O7GED
AC1OFCIP
AC1OFCIV
AC1OFCJ1
AC1OFCJ7
AC1OIBYJ
AC1OIBYL
AC1OIBYN
AC1Q2V4O
Antirobe
BIDD:GT0418
BPBio1_000236
BRD-A23034328-003-03-4
BSPBio_000214
BSPBio_002049
C06914
C18H33ClN2O5S
CAS-21462-39-5
CHEBI:3745
CHEMBL187
CID2786
CID29029
CID3000512
CID3001928
CID3032758
CID3034218
CID446598
CID5702026
CID6602476
CID6604361
CID7048642
CID7048644
CID7048646
CID7048648
CID7276014
CID7276016
CID7276018
CID9812677
CLDM
CLINDA & IL-12
CLY
Chlolincocin
Chlorlincocin
Chlorodeoxylincomycin
Chlorolincomycin
Cleocin
Cleocin (TN)
Cleocin (tn)
Cleocin HCl
Cleocin Hcl
Cleocin Pediatric
Cleocin Phosphate
Cleocin T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
 
Clinda-Derm
ClindaDerm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
Clindamycin
Clindamycin & Interleukin 12
Clindamycin & VRC3375
Clindamycin (USAN/INN)
Clindamycin Hcl
Clindamycin Hydrochloride
Clindamycin Phosphate
Clindamycin [USAN:BAN:INN]
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
D00277
DB01190
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Dalacine
DivK1c_000464
EINECS 242-209-1
Evoclin
HMS2089A05
HMS2089N16
HSDB 3037
I06-0826
IDI1_000464
KBio1_000464
KBio2_000638
KBio2_003206
KBio2_005774
KBio3_001269
KBioGR_000844
KBioSS_000638
Klimicin
Klindan 300
LS-187128
LS-98131
MLS001183714
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
MolPort-002-323-206
MolPort-002-964-479
NCGC00016752-01
NCGC00178843-01
NCGC00179636-01
NINDS_000464
Prestwick0_000137
Prestwick1_000137
Prestwick2_000137
Prestwick3_000137
ResiDerm A
SMP2_000295
SMR000677917
SPBio_000670
SPBio_002153
STK177246
STOCK1N-31150
Sobelin
Spectrum2_000885
Spectrum3_000355
Spectrum4_000292
Spectrum5_001525
Spectrum_000158
U 21251
U-21,251
U-21251
UNII-3U02EL437C
Zindaclin
clindamycin
8
Pyrimethamineapproved, vet_approvedPhase 415258-14-04993
Synonyms:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
46706_FLUKA
46706_RIEDEL
4753 R.P.
4753 r.p
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE
5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine
5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine
58-14-0
AB00052084
AC-7879
AC1L1JDI
AI3-25005
AZT + Pyrimethamine combination
Aventis Brand of Pyrimethamine
BIDD:GT0149
BIDD:PXR0173
BPBio1_000147
BRD-K88429204-001-05-4
BRN 0219864
BSPBio_000133
BSPBio_003282
BW 50-63
BW 5063
C07391
C12H13ClN4
CAS-58-14-0
CCRIS 546
CD
CHEBI:8673
CHEMBL36
CID4993
CP6
CPD000058714
CRL-8131 & Pyrimethamine
CRL-8142 & Pyrimethamine
Chloridin
Chloridine
Chloridyn
D00488
D011739
DB00205
Darachlor
Daraclor
Darapram
Daraprim
Daraprim (TN)
Daraprime
Daraprin
Diaminopyritamin
Disulone
DivK1c_000652
EINECS 200-364-2
EXR-101
Erbaprelina
Ethylpyrimidine
Fansidar
Fansidar (Pyrimethamine/Sulfadoxine)
Glaxo Wellcome Brand of Pyrimethamine
GlaxoSmithKline Brand of Pyrimethamine
HMS1568G15
HMS1920N12
HMS2092E13
HMS502A14
IDI1_000652
KBio1_000652
KBio2_001386
KBio2_003954
 
KBio2_006522
KBio3_002502
KBioGR_001007
KBioSS_001386
Khloridin
L000713
LS-238
Lactoferrin B & Pyrimethamine
Lactoferrin H & Pyrimethamine
MCB-3837
MLS000028606
MLS001148621
MLS002454446
MLS002701881
Malacid
Malocid
Malocide
Maloprim
MolPort-001-783-655
NCGC00016256-01
NCGC00016256-02
NCGC00023188-03
NCGC00023188-04
NCGC00023188-05
NCGC00023188-06
NCGC00023188-07
NCI-C01683
NCI60_002604
NCIOpen2_008313
NINDS_000652
NSC 3061
NSC-3061
NSC3061
Oxaquin
Pirimecidan
Pirimetamin
Pirimetamina
Pirimetamina [INN-Spanish]
Pirimetamina [Spanish]
Prestwick0_000037
Prestwick1_000037
Prestwick2_000037
Prestwick3_000037
Prestwick_504
Primethamine
Pyremethamine
Pyrimethamin
Pyrimethamine (JAN/USP/INN)
Pyrimethamine (Pyr)
Pyrimethamine Hcl
Pyrimethamine [USAN:INN:BAN:JAN]
Pyrimethaminum
Pyrimethaminum [INN-Latin]
RP 4753
S2006_Selleck
SAM002554921
SMR000058714
SPBio_000672
SPBio_002054
SPECTRUM1500520
Spectrum2_000886
Spectrum3_001701
Spectrum4_000494
Spectrum5_001447
Spectrum_000906
TCMDC-123831
TCMDC-125860
Tindurin
Tindurine
Tinduring
UNII-Z3614QOX8W
WLN: T6N CNJ BZ DZ ER DG& F2
WR 2978
Wellcome Brand of Pyrimethamine
ZINC00057464
m alocid
nchembio.215-comp13
nchembio.87-comp22
pyrimethamine
9
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 3427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
10Vitamin B ComplexPhase 4, Phase 34229
11AnalgesicsPhase 4, Phase 3, Phase 211287
12Calcium, DietaryPhase 4, Phase 3, Phase 25525
13VitaminsPhase 4, Phase 35095
14Trace ElementsPhase 4, Phase 35802
15Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 312767
16HormonesPhase 4, Phase 313979
17Hormone AntagonistsPhase 4, Phase 312778
18Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 222776
19Antihypertensive AgentsPhase 44095
20MicronutrientsPhase 4, Phase 35802
21Clindamycin palmitatePhase 4168
22Tocolytic AgentsPhase 4, Phase 3, Phase 2708
23Clindamycin phosphatePhase 4168
24AnestheticsPhase 4, Phase 3, Phase 19001
25calcium channel blockersPhase 4, Phase 31940
26Central Nervous System DepressantsPhase 4, Phase 3, Phase 112806
27AnticonvulsantsPhase 4, Phase 32620
28Anti-Arrhythmia AgentsPhase 4, Phase 32969
29Anti-Bacterial AgentsPhase 410884
30OxytocicsPhase 4, Phase 3, Phase 1660
31Folic Acid AntagonistsPhase 42200
32Anti-Infective AgentsPhase 4, Phase 321402
33AntimalarialsPhase 41216
34Renal AgentsPhase 4732
35Thioctic AcidPhase 4115
36Protective AgentsPhase 4, Phase 37190
37Antiparasitic AgentsPhase 42127
38Antiprotozoal AgentsPhase 41986
39AntioxidantsPhase 4, Phase 32928
40ProgestinsPhase 4, Phase 3546
41Fanasil, pyrimethamine drug combinationPhase 4120
42Artemether-lumefantrine combinationPhase 4138
43FolateNutraceuticalPhase 4, Phase 34279
44Vitamin B9NutraceuticalPhase 4, Phase 34279
45Folinic AcidNutraceuticalPhase 4, Phase 33150
46Alpha-lipoic AcidNutraceuticalPhase 4115
47
Aspirinapproved, vet_approvedPhase 3, Phase 2111250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
 
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
48
DalteparinapprovedPhase 33039041-08-1
Synonyms:
Daltepariininatrium
Dalteparin Sodyum
Dalteparin sodium
Dalteparin sodná sůl
Dalteparin-nátrium
Dalteparina sódica
 
Dalteparinnatrium
Dalteparino natrio druska
Dalteparinum Natricum
Dalteparyna sodowa
Daltéparine sodique
Heparin Fragment KABI 2165
Tedelparin
49
HydroxocobalaminapprovedPhase 324813422-51-011953898, 5460373, 44475014
Synonyms:
13422-51-0
22465-48-1
78091-12-0
8017-22-9
Acti-B12
AlphaRedisol
AlphaRedisol (TN)
Axion
Axlon
Benzimidazolyl ribofuranosyl phosphate deriv.
C08230
C62H85CoN13O15P
CHEBI:27786
CHEMBL1200742
CHEMBL235822
CID11622291
CID11953898
CID5460373
CID6433575
CID6474319
Ciplamin H
Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-hydroxocobamide
Cobalex
Cobalin H
Cobinamide dihydroxide dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Cobinamide, Co-hydroxy-, dihydrogen phosphate (ester), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono (inner salt), 3'- ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Codroxomin
Cyanokit
Cyanokit (TN)
D01027
DB00200
Depogamma
Docclan
Docelan
Docelvita
Docevita
Droxomin
Ducobee Hy
Ducobee-Hy
Duradoce
Duralta-12
EINECS 236-533-2
HSDB 3342
HYDROXOCOBALAMIN
Hidroxocobalamina
Hidroxocobalamina [INN-Spanish]
Hydro Cobex
 
Hydrobamine
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxocobalamin (JAN/USP/INN)
Hydroxocobalamin Vitamin B12
Hydroxocobalamin [USAN:INN:BAN:JAN]
Hydroxocobalamin acetate
Hydroxocobalamin anhydrous
Hydroxocobalamin monohydrochloride
Hydroxocobalamin(alkaline soln.), OH- replaces CN- in Cyanocobalamin)
Hydroxocobalaminacetat
Hydroxocobalamine
Hydroxocobalamine [INN-French]
Hydroxocobalaminum
Hydroxocobalaminum [INN-Latin]
Hydroxocobalaminum anhydrous
Hydroxocobemine
Hydroxomin
Hydroxy Cobal
Hydroxy vitamin B12
Hydroxycob(lll)alamin
Hydroxycobalamin
Hydroxycobalamine
Hyxobamine
Idrogrisevit
Idrossocobalamina
Idrossocobalamina [DCIT]
LS-54607
Lyovit-H
Neo-Betalin 12
Neo-cytamen
Neo-macrabin
Neo-rojamin
OH-Cbl
OH-Duphar
Ohb12
Oxobemin
Oxolamine (arcum)
Primabalt RP
Redisol-H
S1668_Selleck
Sytobex-H
UNII-Q40X8H422O
Vibeden
Vitadurin
Vitamin B(sub 12a)
Vitamin B-12b
Vitamin B12a
Vitamin B12b
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
vitamin B-12b
50
Tranexamic AcidapprovedPhase 32571197-18-85526
Synonyms:
08455_FLUKA
1197-17-7
1197-18-8
1ceb
3-14-00-00868 (Beilstein Handbook Reference)
4-(Aminomethyl)-Cyclohexanecarboxylic Acid
4-(Aminomethyl)cyclohexanecarboxylic acid
4-(aminomethyl)cyclohexane-1-carboxylic acid
857653_ALDRICH
A0236
AB00052260
AB1003647
AC-4687
AC1L1KJH
AC1Q50F3
AC1Q546D
AC1Q5U04
ALBB-006013
AMCA
AMCHA
AMH
AR-1F6595
Acide tranexamique
Acide tranexamique [INN-French]
Acido tranexamico
Acido tranexamico [INN-Spanish]
Acidum tranexamicum
Acidum tranexamicum [INN-Latin]
Amikapron
Amstat
Anvitoff
BAY 3517
BPBio1_000069
BRN 2207452
BSPBio_000061
BSPBio_002837
CAS-1197-18-8
CHEBI:48669
CHEMBL292500
CHEMBL877
CID5526
CL 65336
CL-65336
Carxamin
Cyclocapron
Cyklokapron
Cyklokapron (TN)
D01136
DB00302
DV 79
DV-79
DV79
DivK1c_000655
EINECS 214-818-2
Emorhalt
Exacyl
Frenolyse
HMS1568D03
HMS1921F08
HMS2092P03
HMS502A17
Hexapromin
Hexatron
I04-0993
IDI1_000655
KABI 2161
KBio1_000655
KBio2_001871
KBio2_004439
KBio2_007007
KBio3_002337
KBioGR_000511
 
KBioSS_001871
LS-56611
LS-56612
LT00159441
Mastop
MolPort-001-792-390
MolPort-002-512-008
NCGC00016569-01
NCGC00016569-02
NCGC00016569-03
NCGC00094944-01
NCGC00094944-02
NINDS_000655
NSC 291305
NSC291305
Oprea1_786414
Prestwick0_000171
Prestwick1_000171
Prestwick2_000171
Prestwick3_000171
Prestwick_476
RP 18,429
Rikavarin
Rikavarin (TN)
Rikavarin-S
SPBio_000689
SPBio_001982
SPECTRUM1502026
STK503668
STOCK1N-16183
Spectrum2_000655
Spectrum3_001189
Spectrum4_000046
Spectrum5_001258
Spectrum_001391
Spiramin
Tamcha
Tranex
Tranexamate
Tranexamic acid (JP15/USAN/INN)
Tranexamic acid [USAN:INN:BAN:JAN]
Tranexamic acid cis-form
Tranexamsaeure
Tranexan
Tranexmic acid
Tranhexamic acid
Trans AMCHA
Trans-1-(Aminomethyl)cyclohexane-4-carboxylic acid
Trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid
Trans-p-(Aminomethyl)cyclohexanecarboxylic
Transamin
Transamin (TN)
Transamlon
Trasamlon
UNII-6T84R30KC1
Ugurol
WLN: L6TJ AVQ D1Z -T
cis-4-(Aminomethyl)cyclohexanecarboxylic acid
cis-4-Aminomethylcyclohexane-1-carboxylic acid
cis-AMCHA
t-AMCHA
tranexamic acid
tranexmic acid
trans-1-Aminomethylcyclohexane-4-carboxylic acid
trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid
trans-4-(Aminomethyl)cyclohexane-carboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid ester
trans-4-Aminomethylcyclohexane-1-carboxylic acid
trans-4-aminomethylcyclohexane-1-carboxylic acid
trans-Amcha
trans-Tranexamic acid
trans-p-(Aminomethyl)cyclohexanecarboxylic acid

Interventional clinical trials:

(show top 50)    (show all 68)
idNameStatusNCT IDPhase
1Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)Unknown statusNCT01361425Phase 4
2Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma TreatmentCompletedNCT02601898Phase 4
3Intermittent Preventive Treatment Versus Scheduled Screening and Treatment of Malaria in PregnancyCompletedNCT01084213Phase 4
4Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial VaginosisCompletedNCT00642980Phase 4
5Induction of Labor With a Foley Balloon Catheter: Inflation With 30ml Compared to 60mlCompletedNCT00451308Phase 4
6Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of LaborCompletedNCT02150954Phase 4
7Cerclage vs Cervical Pessary in Women With Cervical IncompetenceRecruitingNCT02405455Phase 4
8Different Schemes of Magnesium Sulfate for PreeclampsiaTerminatedNCT02396030Phase 4
9Folic Acid Dosage and Malformations ReductionUnknown statusNCT01244347Phase 3
10Low Dose Aspirin for the Prevention of PreeclampsiaUnknown statusNCT01890005Phase 3
11Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe PreeclampsiaCompletedNCT00986765Phase 3
12Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual AbortionCompletedNCT00959621Phase 3
13Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)CompletedNCT00014989Phase 3
14Intraumbilical Vein Injection of Oxytocin in Routine Practice for Active Management of the Third Stage of LaborCompletedNCT01094028Phase 3
15Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.CompletedNCT00236340Phase 3
16Can we Use Intravenous Injection of Tranexamic Acid in Routine Practice With Active Management of the Third Stage of Labor?CompletedNCT01338454Phase 3
17TIPPS: Thrombophilia in Pregnancy Prophylaxis StudyCompletedNCT00967382Phase 3
18Controlled Cord Traction During Third Stage of LaborCompletedNCT00781066Phase 3
19Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy LossCompletedNCT00400387Phase 3
20RCT of Antioxidant Therapy to Prevent Preeclampsia in BrazilCompletedNCT00097110Phase 3
21High Dose Folic Acid Supplementation Throughout Pregnancy for Preeclampsia PreventionCompletedNCT01355159Phase 3
22Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)CompletedNCT00099164Phase 3
23Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened MiscarriageRecruitingNCT02128685Phase 3
24Low Dose Aspirin in the Prevention of Preeclampsia in ChinaRecruitingNCT02797249Phase 3
25A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)RecruitingNCT01376778Phase 3
26A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation DisordersRecruitingNCT02336243Phase 3
27Progesterone in Threatened AbortionNot yet recruitingNCT02950935Phase 3
28Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm DeliveryWithdrawnNCT01796522Phase 3
29Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk PregnanciesCompletedNCT01355822Phase 1, Phase 2
30Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM)RecruitingNCT00466128Phase 2
31Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth RestrictionNot yet recruitingNCT02678221Phase 2
32Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe PreeclampsiaTerminatedNCT02286284Phase 2
33Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of LaborRecruitingNCT02680938Phase 1
34A Comparison of B Type Natriuretic Peptide Levels and Hemodynamics Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women - A Pilot StudyRecruitingNCT02527018Phase 1
35Spinal Analgesia Versus No Analgesia: Study for External Cephalic VersionTerminatedNCT00119184Phase 1
36Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma ActivityUnknown statusNCT00573118
37Relation Between Subclinical Hypothyroidism and Outcome of PregnancyUnknown statusNCT01335802
38Early Prevention of Preeclampsia StudyUnknown statusNCT01547390
39Pre-Eclampsia Prediction By Doppler Screening Of Uterine Arteries And Angiogenic Factors In Second Trimester Of PregnancyUnknown statusNCT00725660
40Comparison of Efficiency Between Practicing of Knee Chest Position and External Cephalic Version in Cases of Breech Presentation.Unknown statusNCT02167841
41The Reduced Thyroid Function of the Premature Newborn: Relation With Molecular Changes in the Placenta and Maternal Thyroid Hormone Status and Neurodevelopmental ImplicationsUnknown statusNCT01466023
42The Prognosis of Early Pregnancy With Post Coital BleedingUnknown statusNCT02363569
43İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels?Unknown statusNCT01906567
44Optimizing Technology-Delivered Interventions for Smoking in Pregnancy: The Mommy Check-Up Study.Unknown statusNCT02340624
45The SMART-ORACLE StudyUnknown statusNCT01932671
46Pregnancy Outcome in Woman With Threatened AbortionCompletedNCT02686112
47Pelvic Examination in PregnancyCompletedNCT01570413
48Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational StudyCompletedNCT01525563
49Prevention of Post-partum HaemorrhageCompletedNCT01044082
50Comparing Blood Loss During Caesarean Section Between Manual Separation of Placenta & Conservative ManagementCompletedNCT02480556

Search NIH Clinical Center for Placental Abruption


Cochrane evidence based reviews: abortion, threatened

Genetic Tests for Placental Abruption

About this section

Anatomical Context for Placental Abruption

About this section

MalaCards organs/tissues related to Placental Abruption:

35
Placenta, Uterus, Testes, Brain, Thyroid, Liver, Heart

Animal Models for Placental Abruption or affiliated genes

About this section

MGI Mouse Phenotypes related to Placental Abruption:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.9ENG, F2, F5, MTHFR, PGF, THBD
2MP:00053877.9EBAG9, F2, FLT1, MTHFD1, PGF, SERPINC1
3MP:00053977.7EBAG9, ENG, F2, FLT1, MTHFD1, SERPINC1
4MP:00053787.6ENG, F2, F5, FLT1, MTHFD1, MTHFR
5MP:00053857.6ENG, F2, F5, FLT1, MTHFD1, PGF
6MP:00053807.6ENG, F2, F5, FLT1, MTHFD1, PGF
7MP:00107687.2APOH, ENG, F2, F5, FLT1, MTHFD1
8MP:00053766.9APOH, ENG, F2, F5, FLT1, MTHFD1
9MP:00036316.8ENG, F2, F5, FLT1, MTHFD1, MTHFR

Publications for Placental Abruption

About this section

Articles related to Placental Abruption:

(show top 50)    (show all 339)
idTitleAuthorsYear
1
Does apoptotic activity have a role in the development of the placental abruption? (27893299)
2016
2
Trauma in pregnant women: assessing detection of post-traumatic placental abruption on contrast-enhanced CT versus ultrasound. (27853848)
2016
3
Abnormal patterns of blood flow through the uterine arteries: Is it a clue for placental abruption in clinically suspected cases? (25774964)
2015
4
Circadian clock-related genetic risk scores and risk of placental abruption. (26515929)
2015
5
Association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with preterm delivery and placental abruption: a systematic review and meta-analysis. (26439908)
2015
6
Placental abruption: Are we going to lose them both? (25871760)
2015
7
Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report. (25532532)
2014
8
Is there an association between a history of placental abruption and long-term maternal renal complications? (25234099)
2014
9
Predictors of perinatal mortality associated with placenta previa and placental abruption: an experience from a low income country. (25002975)
2014
10
Risk factors for perinatal mortality in patients admitted to the hospital with the diagnosis of placental abruption. (24888498)
2014
11
Risk factors of placental abruption. (24174950)
2013
12
Decreasing perinatal mortality in placental abruption. (23072758)
2013
13
Placenta praevia, placental abruption and amphetamine use in pregnancy: a case study. (23266230)
2013
14
Placental abruption and placental weight - implications for fetal growth. (23750805)
2013
15
Is the perinatal outcome of placental abruption modified by clinical presentation? (21490793)
2011
16
Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects. (21430195)
2011
17
Alcohol consumption during pregnancy and risk of placental abruption and placenta previa. (20437196)
2011
18
Hysterotomy and evacuation of a deciduate placental hematoma following placental abruption. (20624620)
2010
19
Self-reported smoking habits and serum cotinine levels in women with placental abruption. (21050148)
2010
20
Risk of placental abruption in relation to migraines and headaches. (20977769)
2010
21
Does placenta position modify the risk of placental abruption in car crashes? (19675977)
2009
22
The increase in metallothionein and ectopic decidual immunoreactivity with respect to the progression of labor at term and the lack of analogical changes in placental abruption. (18782281)
2008
23
Reduced folate carrier 80A-->G polymorphism, plasma folate, and risk of placental abruption. (18629538)
2008
24
Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption. (17960788)
2007
25
Risk and risk estimation of placental abruption. (16202500)
2006
26
Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways. (16582113)
2006
27
Pregnancy outcomes in placental abruption. (17128829)
2006
28
Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions. (16513243)
2006
29
Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption. (14962795)
2004
30
Could placental abruption be an antiphospholipid antibody related disorder? (15144143)
2004
31
Sucessful pregnancy outcome following three severe placental abruptions and intrauterine fetal death in the patient--heterozygous carrier of R506Q mutation of factor V (Leiden)]. (15518286)
2004
32
Interventions for treating placental abruption. (12535464)
2003
33
Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. (12959223)
2003
34
The profile and complications of women with placental abruption and intrauterine death. (12929885)
2003
35
Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. (12380602)
2002
36
Placental abruption. (11997676)
2002
37
Placental abruption and adverse perinatal outcomes. (10553791)
1999
38
Is fetal gender significant in the perinatal outcome of pregnancies complicated by placental abruption? (15512413)
1999
39
The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence. (9800939)
1998
40
Plasma fibrin D-dimer in pregnancies complicated by partial placental abruption. (9323905)
1997
41
Maternal serum alpha-fetoprotein in placental abruption associated with preterm labor. (9127154)
1997
42
Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy. (9166200)
1997
43
Placental abruption after insertion of catheter tip intrauterine pressure transducers: a report of four cases. (8926614)
1995
44
Placental abruption following placement of disposable intrauterine pressure transducer system. (8442792)
1993
45
Delayed cesarean section in preeclampsia with placental abruption and fetal distress. (1890480)
1991
46
Relationship between antepartum cocaine abuse, abnormal umbilical artery Doppler velocimetry, and placental abruption. (2067775)
1991
47
Pulmonary thromboembolism complicating recurrent placental abruption at 29 weeks' gestation. (2400355)
1990
48
Uteroplacental and umbilical artery blood velocity waveforms in placental abruption assessed by Doppler ultrasound. (2930753)
1989
49
Placental abruption associated with cocaine abuse. (3285653)
1988
50
Expectant management of partial placental abruption in previable pregnancies. A report of two cases. (3316649)
1987

Variations for Placental Abruption

About this section

Expression for genes affiliated with Placental Abruption

About this section
Search GEO for disease gene expression data for Placental Abruption.

Pathways for genes affiliated with Placental Abruption

About this section

GO Terms for genes affiliated with Placental Abruption

About this section

Cellular components related to Placental Abruption according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00056157.1APOH, ENG, F2, F5, FLT1, PGF

Biological processes related to Placental Abruption according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1blood coagulation, intrinsic pathwayGO:000759710.3APOH, F2
2negative regulation of platelet activationGO:001054410.2F2, THBD
3regulation of blood coagulationGO:003019310.2APOH, F2
4negative regulation of blood coagulationGO:003019510.1APOH, THBD
5methionine metabolic processGO:000655510.0MTHFD1, MTHFR
6sprouting angiogenesisGO:00020409.9ENG, PGF
7positive regulation of collagen biosynthetic processGO:00329679.9ENG, F2
8tetrahydrofolate interconversionGO:00359999.9MTHFD1, MTHFR
9positive regulation of blood coagulationGO:00301949.9APOH, F2
10negative regulation of fibrinolysisGO:00519189.7APOH, F2, THBD
11folic acid metabolic processGO:00466559.5MTHFD1, MTHFR
12response to hypoxiaGO:00016669.3FLT1, MTHFR, PGF
13positive regulation of angiogenesisGO:00457669.2ENG, FLT1, PGF
14blood coagulationGO:00075969.1F2, F5, SERPINC1, THBD

Molecular functions related to Placental Abruption according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1heparin bindingGO:00082019.3APOH, PGF, SERPINC1

Sources for Placental Abruption

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet